Spain reviews last years of Insalud:
This article was originally published in Clinica
Executive Summary
Spain has increased spending on healthcare to 6.18% and 6.94% above GDP in each of the last two years, health minister Celia Villalobos announced in parliament at the end of 2001, as it was preparing to complete its national healthcare devolution programme (see this page). Since 1997, per capita spending on healthcare has been raised 30% to over Pta123,000 ($660). Insalud, the now all but defunct healthcare provider to 10 of the country's 17 regions, performed in 2000 and 2001 some 59,000 surgical interventions more than in 1999 and attended 458,000 more general appointments and 700,000 more emergencies over the last two years.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.